Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis

The use of vitamin K antagonists (VKAs), the cornerstone treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived risk of serious bleeding in Asia. Non-VKA oral anticoagulants (NOACs) are safer alternatives. Here, we evaluate performance differences of NOACs...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kang-Ling, Lip, Gregory Y.H., Lin, Shing-Jong, Chiang, Chern-En
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542566/
https://www.ncbi.nlm.nih.gov/pubmed/26304863
http://dx.doi.org/10.1161/STROKEAHA.115.009947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542566/
https://www.ncbi.nlm.nih.gov/pubmed/26304863
http://dx.doi.org/10.1161/STROKEAHA.115.009947

Ejemplares similares